Welcome to Multibagg AI
Log in to access personalized features
Textiles
Textiles - Others
409 Cr
Low Risk
27.8
21.1
0.5
5.6
295.40
167.35
Sales CAGR
Profit CAGR
ROE
ROCE
Bearish
7
Neutral
4
Bullish
3
Bearish
7
Neutral
16
Bullish
23
Bearish
0
Neutral
12
Bullish
20
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
25.50 | 585 Cr | 26.29 | 4.81 | 0.00 | 18.49 | 17.50 | 8.26 | |
288.50 | 409 Cr | 27.77 | 5.62 | 0.00 | 0.00 | 0.00 | 7.99 | |
225.90 | 408 Cr | 22.70 | 2.58 | 0.00 | 12.26 | 11.11 | 2.77 | |
2.48 | 353 Cr | 10.33 | 0.55 | 0.00 | 5.92 | 9.08 | 2.78 | |
8.86 | 339 Cr | 556.26 | 5.40 | 0.00 | 0.55 | 2.07 | -1.71 | |
399.00 | 288 Cr | 17.73 | 3.03 | 0.00 | 15.30 | 14.06 | 7.39 | |
96.90 | 234 Cr | 15.43 | 2.20 | 0.00 | 16.42 | 16.71 | 7.02 |
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
Encompass Design India Ltd (ENCOMPAS) is currently trading at 288.50 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Encompass Design India Ltd operates in the Textiles sector. Review the About Company section on this page to understand its business model, revenue streams, and key products or services.
Over the past 52 weeks, Encompass Design India Ltd has traded between a low of ₹167.35 and a high of ₹295.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Encompass Design India Ltd has a market capitalization of approximately 409.20. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Encompass Design India Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 27.77 and operates in the Textiles sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 409.20 Cr, Encompass Design India Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Encompass Design India Ltd operates in the Textiles sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Encompass Design India Ltd is 27.77. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Board Meeting Outcome
Board approved variation of IPO prospectus objects to reallocate 2.87% of IPO proceeds to working capital, noted 87.45% proceeds already utilised, approved EGM notice and scrutinizer appointment, and approved incorporation of an Indian pharma/nutraceutical subsidiary.
Board Meeting Outcome
Board approved reallocation of 2.87% of IPO proceeds to working capital (to be placed before members via special resolution), approved incorporation of an India-based pharmaceutical/nutraceutical subsidiary, and fixed EGM notice and scrutinizer.
Extra-Ordinary General Meeting
Notice of Extra‑Ordinary General Meeting on March 30, 2026 to seek shareholder approval to vary IPO objects and reallocate ₹115.57 lakh (₹27.60L repayment + ₹87.97L issue expenses) to working capital; remote e‑voting Mar 27–29, cut‑off Mar 23, 2026.
Board Meeting Outcome
Board approved reallocation of 2.87% of IPO proceeds to working capital, approved EGM notice and appointment of scrutinizer for shareholder approval, and approved proposal to incorporate a subsidiary in India (pharmaceuticals/nutraceuticals).
